Endo International PLC (NASDAQ:ENDP)
| 5.82 Delayed Data As of Jan 27 |  -0.10 / -1.69%Today’s Change | 1.97 Today|||52-Week Range 12.49 | +24.09% Year-to-Date |
Latest ENDP News | Press Releases
| 3 Big Winners From the "Super Bowl of Healthcare" Jan 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.92 |
| Today’s open | 5.61 |
| Day’s range | 5.55 - 5.97 |
| Volume | 3,980,316 |
| Average volume (3 months) | 7,980,578 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 01/27/2020
Growth & Valuation
| Earnings growth (last year) | +49.45% |
| Earnings growth (this year) | -23.85% |
| Earnings growth (next 5 years) | -3.15% |
| Revenue growth (last year) | -15.04% |
| P/E ratio | NM |
| Price/Sales | 0.55 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ESPREsperion Therapeutic... | +2.19 | +4.46% |
| TGTXTG Therapeutics Inc | -0.34 | -2.52% |
| ZEALZealand Pharma A/S | -0.55 | -1.51% |
| YMABY-mAbs Therapeutics,... | -0.20 | -0.57% |
Data as of 4:00pm ET, 01/27/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | $0.56 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | -$1.0B |
| Net profit margin | -32.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
